Intelligence · Clinical Development
Pipeline search results
Programs matching “selinexor” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "selinexor" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
SELINEXOR for endometrial cancer
Karyopharm Therapeutics Inc
endometrial cancer
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Dedifferentiated Liposarcoma
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Multiple Myeloma
12 trials -
Selinexor
Karyopharm Therapeutics Inc
Endometrial Cancer
2 trials -
Selinexor (combination therapy)
Karyopharm Therapeutics Inc
Relapsed/Refractory Diffuse Large B-cell Lymphoma
1 trial -
CHOP+selinexor+5-Azacitidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral T Cell Lymphoma
1 trial -
IST-342
Karyopharm Therapeutics Inc
Relapsed Multiple Myeloma
1 trial -
Open Label Selinexor
Karyopharm Therapeutics Inc
Thymoma
1 trial -
SELINEXOR
Karyopharm Therapeutics Inc
Myelofibrosis
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Myelofibrosis
2 trials -
Selinexor
Karyopharm Therapeutics Inc
Thymoma
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Multiple Myeloma in Relapse
1 trial -
Selinexor
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia (Relapsed/Refractory)
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Peripheral T-cell Lymphoma (PTCL)
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Diabetic Foot Ulcers
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Glioblastoma
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Coronavirus Infection
2 trials -
Selinexor
Karyopharm Therapeutics Inc
Acute Myeloid Leukemia (AML)
3 trials -
Selinexor
Karyopharm Therapeutics Inc
Acute Myeloid Leukemia (Relapsed/Refractory)
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Acute Myeloid Leukemia
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Carcinoma, Neuroendocrine
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Breast Cancer
1 trial -
Selinexor
Hospital Authority, Hong Kong
Acute Myeloid Leukemia, Adult
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Diffuse Large B-cell Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.